Found 59 matching trials
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma PHASE1 This is a feasibility study in patients with localized or metastatic soft t...
Show More Location
Monter Cancer Center (Northwell Health)
Learn More & Join Trial
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) PHASE2 Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading c...
Show More Location
City of Hope /ID# 261468
Learn More & Join Trial
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC PHASE3 This multicenter, prospective, randomized, controlled, open-label, two-arm ...
Show More Location
Jinan, Shandong 0531
Learn More & Join Trial
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy PHASE3 This phase III trial compares survival in urothelial cancer patients who st...
Show More Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Microbiome Immunotherapy Toxicity and Response Evaluation N/A This is a observational study to investigate how the microbiome correlates ...
Show More Location
Royal United Hospitals Bath NHS Foundation Trust
Learn More & Join Trial
Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer NA The purpose of this study is to evaluate the efficacy of radiotherapy as pa...
Show More Location
Center of Oncology of the Lublin Region St. Jana z Dukli in Lublin
Learn More & Join Trial
Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001) PHASE3 This study is expected to enroll 182 patients with partial response or stab...
Show More Location
Multiple Locations
Learn More & Join Trial
Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis PHASE1 The main purpose of this investigational research study is to determine how...
Show More Location
Northwestern University
Learn More & Join Trial
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) PHASE3 The purpose of this study is to evaluate the efficacy and safety of atezoli...
Show More Location
Stanford University
Learn More & Join Trial
Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction N/A Immune checkpoint inhibitors (ICIs) might have high grade immune-related ad...
Show More Location
AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM.
Learn More & Join Trial